Skip to main content

Table 3 Comparison of MSH3 and MSH6 genes’ fold change among the studied breast cancer patients as regards presence of toxicity

From: Down-regulation of MSH3 and MSH6 genes in female breast cancer patients receiving taxane-based therapy

Type of toxicity

MSH3fold change

Mean ± SE

MSH6fold change

Mean ± SE

Presence of toxicity

Yes

No

0.086 ± 0.01

0.139 ± 0.03

0.179 ± 0.03

0.315 ± 0.07

p value

 

0.133

0.038*

Peripheral neuropathy

Yes

No

0.089 ± 0.02

0.114 ± 0.02

0.182 ± 0.03

0.259 ± 0.05

p value

 

0.365

0.145

Peripheral neuropathy toxicity grade

   

N = 68

0–1

0.127 ± 0.02

0.242 ± 0.03

N = 37

2–4

0.07 ± 0.02

0.136 ± 0.03

p value

 

0.034*

0.01*

Diarrhea

Yes

No

0.057 ± 0.01

0.108 ± 0.02

0.122 ± 0.03

0.229 ± 0.03

p value

 

0.02*

0.008**

Dyspnea

Yes

No

0.043 ± 0.01

0.102 ± 0.01

0.092 ± 0.04

0.218 ± 0.03

p value

 

0.01*

0.016*

Bone pain

Yes

No

0.075 ± 0.01

0.130 ± 0.03

0.158 ± 0.03

0.281 ± 0.05

p value

 

0.062

0.024*

Fatigue

Yes

No

0.089 ± 0.04

0.10 ± 0.01

0.167 ± 0.06

0.22 ± 0.03

p value

 

0.747

0.367

Gastritis

Yes

No

0.096 ± 0.05

0.098 ± 0.01

0.178 ± 0.08

0.213 ± 0.03

p value

 

0.956

0.595

Nausea

Yes

No

0.091 ± 0.02

0.099 ± 0.02

0.211 ± 0.06

0.206 ± 0.03

p value

 

0.819

0.943

Vomiting

Yes

No

0.098 ± 0.02

0.097 ± 0.02

0.235 ± 0.06

0.202 ± 0.03

p value

 

0.980

0.625

Skin rash

Yes

No

0.097 ± 0.01

0.097 ± 0.07

0.109 ± 0.08

0.211 ± 0.03

p value

 

0.999

0.448

Stomatitis

Yes

No

0.013

0.095 ± 0.01

0.304

0.201 ± 0.02

p value

 

0.773

0.649

  1. *Statistically significant (p < 0.05) **statistically highly significant (p < 0.01)
  2. SE: standard error